Legal Representation
Attorney
R. Gwen Peterson
USPTO Deadlines
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 8, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 8, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 24, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jul 24, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 24, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 24, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 27, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 27, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 27, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 27, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 27, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 26, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 31, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 27, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 27, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 27, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 29, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 27, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 27, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 27, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 8, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 14, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 14, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 8, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 3, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 30, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
Additional Information
Design Mark
The mark consists of a stylized capital letter "A".
Classification
International Classes
005